Privosegtor

DRUG2 trials

Sponsors

Oculis Operations SARL, Oculis

Conditions

Optic Neuritis

Phase 3

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

RecruitingNCT07623668

OculisOptic Neuritis

Start: 2026-05-28End: 2028-12-01Target: 210Updated: 2026-08-14

A Randomized, Double-Masked, Placebo-Controlled Study Assessing the Efficacy and Safety Of Privosegtor (OCS-05) as add-on to IV Methylprednisolone in Participants with Optic Neuritis (PIONEER 1)

Not yet recruitingCTIS2025-525075-91-00

Oculis Operations SARLOptic Neuritis

Target: 34Updated: 2026-08-21